Suppr超能文献

弥漫性冠状动脉疾病支架置入术的早期及长期结果

Early and long-term results of stenting of diffuse coronary artery disease.

作者信息

Di Sciascio G, Patti G, Nasso G, Manzoli A, D'Ambrosio A, Abbate A

机构信息

Department of Cardiovascular Sciences, Campus BioMedico University, Rome, Italy.

出版信息

Am J Cardiol. 2000 Dec 1;86(11):1166-70. doi: 10.1016/s0002-9149(00)01197-8.

Abstract

Diffuse coronary artery disease (CAD) is considered unfavorable for interventional procedures; however, the results of stenting of diffuse CAD have not been completely characterized. We performed stenting in 100 consecutive patients with diffuse CAD, defined as significant stenosis >20 mm (n = 59 patients), multiple significant stenoses in the same artery (n = 23 patients), or significant narrowing involving the whole length of the coronary artery (n = 18 patients). Angiographic success was achieved in 103 arteries (100%) and clinical success was obtained in all 100 patients. There were no deaths; no patient had stent closure, acute myocardial infarction, or required emergency coronary artery bypass surgery. All 100 patients had >6 months follow-up (mean 18 +/- 7 months, range 7 to 31); 77 (77%) remained asymptomatic, and 5 (5%) had acute myocardial infarction, of whom 2 died (2%). In-stent restenosis was observed in 12 patients (12%) and repeat angioplasty was performed in 10. Including those patients who underwent repeat angioplasty, 89 (89%) maintained clinical improvement and 95 (95%) were alive and free of bypass surgery during follow-up. Life-table analysis showed 86% freedom from death, myocardial infarction, and target lesion revascularization at 28 months. Thus, selected patients with diffuse CAD may be treated with satisfactory acute and long-term results by stent implantation.

摘要

弥漫性冠状动脉疾病(CAD)被认为不利于介入手术;然而,弥漫性CAD支架置入术的结果尚未完全明确。我们对100例连续性弥漫性CAD患者进行了支架置入术,这些患者被定义为:显著狭窄>20 mm(n = 59例患者)、同一动脉内多个显著狭窄(n = 23例患者)或冠状动脉全长显著狭窄(n = 18例患者)。103条动脉(100%)实现了血管造影成功,所有100例患者均取得了临床成功。无死亡病例;无患者发生支架闭塞、急性心肌梗死或需要急诊冠状动脉搭桥手术。所有100例患者均进行了>6个月的随访(平均18±7个月,范围7至31个月);77例(77%)仍无症状,5例(5%)发生急性心肌梗死,其中2例死亡(2%)。12例患者(12%)观察到支架内再狭窄,10例患者接受了再次血管成形术。包括接受再次血管成形术的患者在内,89例(89%)在随访期间保持临床改善,95例(95%)存活且未接受搭桥手术。生命表分析显示,在28个月时,86%的患者无死亡、心肌梗死和靶病变血运重建。因此,选择合适的弥漫性CAD患者进行支架植入术,可获得满意的近期和远期效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验